The clinician's prescribing decision is final, payment does not guarantee a prescription, and any decision about whether to start, continue, or stop a GLP-1 treatment should be made in consultation with a qualified licensed healthcare professional
who use Mounjaro are paying privately, according to industry estimates, meaning most will feel the impact of the change
Research for additional uses is being conducted as there is belief in the medical and scientific communities that these drugs may assist in treating a wide range of conditions, such as hypertension, addiction, heart failure, kidney disease, sleep apnea, osteoarthritis, and possibly Parkinsons and Alzheimers disease
How Long Does Tirzepatide Fatigue Usually Last